Profile
Jesse M.
Cedarbaum is the founder of Coeruleus Clinical Sciences LLC.
He currently holds positions as Director at American Society For Neurological Therapeutics, Member at American Neurological Association, and Venture Advisor at Israel Biotech Fund.
Previously, he worked as VP-Neurology Early Clinical Development at Biogen, Inc. from 2015 to 2019 and as Vice President-Clinical Research & Operations at Cytokinetics, Inc. He received his undergraduate degree from Stanford University and his doctorate from Yale University.
Jesse M. Cedarbaum active positions
| Companies | Position | Start |
|---|---|---|
American Neurological Association
American Neurological Association Internet Software/ServicesTechnology Services Provides a platform which publishes content about neurology addiction and recovery disorders | Corporate Officer/Principal | 2011-10-30 |
American Society For Neurological Therapeutics | Director/Board Member | 2011-10-30 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Coeruleus Clinical Sciences LLC
Coeruleus Clinical Sciences LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic and operational consulting services to pharmaceutical, biotechnology & medical device companies | Founder | - |
Former positions of Jesse M. Cedarbaum
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2019-06-30 |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Training of Jesse M. Cedarbaum
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Neurological Association
American Neurological Association Internet Software/ServicesTechnology Services Provides a platform which publishes content about neurology addiction and recovery disorders | Technology Services |
American Society For Neurological Therapeutics | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Coeruleus Clinical Sciences LLC
Coeruleus Clinical Sciences LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic and operational consulting services to pharmaceutical, biotechnology & medical device companies | Commercial Services |
- Stock Market
- Insiders
- Jesse M. Cedarbaum
















